Bidi Medical was awarded the Ram Chalan Management Practice Award
我放心你带套猛
发表于 2023-10-28 14:17:24
259
0
0
Our reporter Xu Yiming interned reporter Jin Wanxia
On October 27th, at the 100th anniversary of the founding of Harvard Business Review in China, Deng Jianmin, Global Senior Vice President and General Manager of Greater China at Bidi Healthcare, was awarded the Outstanding Award at the 2023 Ram Charan Management Practice Award for his project "Finding a Balance between Stability and Flexibility - A Way to Reinventing Leadership in Mid-Level and Senior Management of Bidi China", in recognition of his foresight in leading Bidi Healthcare in talent cultivation and development Creativity and transformative power.
Deng Jianmin, Global Senior Vice President and General Manager of Greater China at Bidi Medical, said, "Talent is one of the driving forces for Bidi Medical's innovation in China and a major advantage of differentiated competition. I am honored to receive this award, which is a recognition of Bidi Medical's talent cultivation and innovation. We also hope to help create innovation driving forces and empower business growth by empowering localized talents and leadership breakthroughs
The Ram Charan Management Practice Award is a non-profit management award jointly initiated by the Chinese version of Harvard Business Review and world-class management consulting master Mr. Ram Charan. It represents the highest honor of Chinese management practice and aims to recognize enterprises and corporate executives who have made innovative and reference contributions in China's management practice, and to build a platform for Chinese enterprises to learn management practice experience.
The "BAP Business Acceleration Program Leading Business Acceleration" project proposed by Bidi Medical this time is a talent development project aimed at middle-level core leaders. This project closely aligns with the company's 2025 business strategy, focusing on growth, empowerment, and simplification, integrating professor resources and ecosystem cooperation from multiple top universities. With practical content from five modules, from strategic corporate finance to business war simulation, it cultivates talents with the ability to respond to future business challenges, fully meeting the needs of different levels.
Deng Jianmin stated: In the face of the opportunities and challenges faced by the healthcare industry in the era of great change, the breakthroughs and transformations of managers are important factors that deeply affect organizational development. The mainstream 'professional manager style' leaders in the healthcare industry urgently need to transform towards leaders with more foresight, creativity, and transformative abilities, seeking a balance between stability and flexibility, while also possessing strong resilience, foresight, agility, openness, and empathy
During his more than ten years as the Global Senior Vice President and General Manager of Greater China at Bidi Medical, Adhering to the strategy of "Rooting in China and Serving China", Bidi Medical has established a complete value chain system in China, covering the entire process of operation from research and development, production, supply chain, market, sales to after-sales service. It has gradually formed a business ecosystem with Bidi as the core, continuously deepening Bidi Medical's localization layout in China, especially " Localization of Talents - Bidi Medical hopes to further empower localized talents with professional skills and leadership breakthroughs, and simultaneously assist in the high-quality development of China's medical industry.
In addition to BAP, Bidi Medical tailors hierarchical leadership development plans for managers at different levels, including the "GMGM General Manager Leadership Development Project" tailored for senior leaders and the "& Quot; LAP Leadership Acceleration Program Senior Manager Leadership Acceleration& Quot; Projects, etc., help managers at different levels build clear leadership growth paths, while supporting the rapid growth of Bidi Medical's business, it also accumulates a strong reserve of leadership talents to promote industry change.
In addition to reshaping and upgrading leadership, Bidi Medical has always regarded the development and cultivation of talents as an important pillar for the company to achieve strategic implementation. In Deng Jianmin's view, when enterprises prioritize the cultivation of professional composite talents, human subjective initiative will quickly produce spillover effects. This strategy of combining personal growth with company growth not only enhances the company's soft competitiveness and attracts more high-quality talents, but also plays a positive role in improving the talent level of the entire industry and promoting the overall progress of the industry.
All along, Bidi Medical has always adhered to the principle of "leading the world in health", adhered to the principle of "putting patients at the center", and is committed to solving the most challenging and urgent health needs in the world. As a pioneer of multiple disruptive innovative medical technologies and devices, Bidi Medical continuously innovates around the needs of patients driven by technological innovation. Over the past 30 years of development in China, Bidi Medical has continuously strengthened the cultivation and construction of talent localization, rooted in the local market, promoted innovation, and promoted sustainable development. In the future, Bidi Medical will continue to actively build an innovation platform and bridge for the global medical technology industry, empower the construction of local medical ecosystems, and promote the development of local talents, "based in China, going global", continuously leading the innovation and progress of China and the global medical industry.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
-
今日になっても、世界中のスタンダード500指数投資家は、データセンターのサーバーメーカーである超マイクロコンピュータの説明を待っていない--なぜ一時上昇幅が大きかったAI概念株が、スタンダード500指数に入っ ...
- 就放荡不羁就h
- 前天 12:46
- 支持
- 反对
- 回复
- 收藏
-
【第3四半期の損失は11.39億元に縮小し、領克極クリプトンの安聡明さを統合する予定:来年損益のバランスを実現する】業績報によると、極クリプトンの2024年第3四半期の総売上高は183.6億元で、前年同期比31%増加し ...
- 小姆
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
財中社は11月15日、BOSS直招(02076/BZ)が公告を発表し、会社が2024年11月14日に初めて公開したアフターサービス株式計画に基づいて、自主的に市場でA類普通株37万株を買い戻し、会社の発行済みおよび流通済み株式 ...
- 孤独的男孩
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
11月14日、ダダグループ(ナスダックコード:DADA)は2024年第3四半期の業績報告を発表し、第3四半期、同社の売上高は前年同期比7.3%減の24.294億元、前年同期は26.218億元、Non-GAAPの純利益は5900万元の赤字で、 ...
- 东篱585
- 3 天前
- 支持
- 反对
- 回复
- 收藏